-+ 0.00%
-+ 0.00%
-+ 0.00%

Iterum Therapeutics Reaches Rebate Milestone, Obtains Patent

Benzinga·02/13/2026 13:05:34
Listen to the news

ITRM reaches another signed rebate agreement with one of the top three Medicare Part D Pharmacy Benefit Managers;

Iterum has been granted a patent in the United States  that covers a bilayer tablet comprising sulopenem etzadroxil and probenecid.